Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It also helps your body utilize carbohydrates for energy and support healthy blood sugar levels
DEVOTE landmark safety outcomes trial Tresiba U-100 demonstrated no increased risk of major adverse cardiovascular events (MACE) vs insulin glargine U-100 for adults with type 2 diabetes and ASCVD 2,d The secondary confirmatory endpoint showed Tresiba U-100 also demonstrated statistically significant lower rates of severe hypoglycemic events vs insulin glargine U-100 2,e A flat and stable profile 2-4 Tresiba provides a steady rate of absorption into the bloodstream, giving it a flat and stable profile at steady state
Based on these findings, experts suggest that a 5-amino-1MQ cycle should last about four weeks on and four weeks off, as this ensures a more cautious approach for administering the novel compound
Contact Klinic to start your transformative journey towards a healthier body and life
